Skip to content

Clinical trials

Head and Neck Neoplasms trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Country / region: Malaysia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20142
20151
20191
20224
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting4
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Universiti Sains Malaysia2
Bicara Therapeutics1
Inhibrx Biosciences, Inc1
Kura Oncology, Inc.1
Merus B.V.1
Tessa Therapeutics1
University College, London1
University of Malaya1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms12
Squamous Cell Carcinoma of Head and Neck4
Laryngeal Diseases2
Recurrence2
Anxiety Disorders1
Camurati-Engelmann Syndrome1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1
Epstein-Barr Virus Infections1
Hypopharyngeal Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.